FRTX

Fresh Tracks Therapeutics, Inc. Common Stock

FRTX

Capitalización de mercado USD 4.72 M

Excluida de cotización

FRTX dejó de cotizar en bolsa el 18 de diciembre de 2023.

Acerca de: Fresh Tracks Therapeutics Inc is a clinical-stage pharmaceutical company striving to transform patient lives through the development of innovative and differentiated prescription therapeutics.

Empleados: 13

Salud Fabricantes de medicamentos - General

Noticias

Positivo

Neutral

Negativo

Sentimiento 3 meses

Positivo 0%

Neutral 0%

Negativo 0%

Neutral

GlobeNewsWire

hace 2 años

Fresh Tracks Therapeutics Announces its Common Stock will be Suspended from Trading on Nasdaq at Open of Business on December 19th

Common stock expected to begin trading on over-the-counter market following suspension Common stock expected to begin trading on over-the-counter market following suspension

Neutral

GlobeNewsWire

hace 2 años

Fresh Tracks Therapeutics Announces Third Adjournment of Special Meeting of Stockholders

Meeting adjourned to December 27, 2023 at 10 a.m. MT

Neutral

GlobeNewsWire

hace 2 años

Fresh Tracks Therapeutics Announces Second Adjournment of Special Meeting of Stockholders

Meeting adjourned to December 15, 2023 at 10 a.m. MT

Neutral

GlobeNewsWire

hace 2 años

Fresh Tracks Therapeutics Announces Adjournment of Special Meeting of Stockholders

Meeting adjourned to November 30, 2023 at 10 a.m. MT Fresh Tracks encourages all stockholders of record on October 17, 2023 who have not yet voted to do so by 11:59 p.m.

Ver rankings de noticias

Gráficos de precios implementados con Lightweight Charts™

Fresh Tracks Therapeutics, Inc. Common Stock FRTX Capitalización de mercado USD 4.72 M

Noticias

Fresh Tracks Therapeutics, Inc. Common Stock

FRTX

Capitalización de mercado USD 4.72 M